October

October 19, 2014

Inerleukin-based therapy for cancer: IL-1β suppresses the expression of Notch1 and Notch2 via up regulation of its target gene, 19/October/2014, 8.51 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Citation: Boominathan, Inerleukin-based therapy for cancer: IL-1β suppresses the expression of Notch1 and Notch2 via up regulation of its target gene, 19/October/2014, 8.51 […]
October 19, 2014

MiRNA-based therapy for Alzhemer’s disease and tauopathies: MiRNA-100 decreases tau phosphorylation and ameliorates tau pathology via down regulation of its target gene, 19/October/2014, 8.40 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, L., MiRNA-based therapy for Alzhemer’s disease and tauopathies: MiRNA-100 decreases tau phosphorylation and ameliorates tau pathology via […]
October 19, 2014

Life-extention therapy for Males: Stem cell protein Oct-4 increases male longevity via up regulation of its target gene, 19/October/2014, 8.18 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, L., Life-extention therapy for Males: Stem cell protein Oct-4 increases male longevity via up regulation of its […]
October 19, 2014

Physiological and Pathological mechanisms that control glycolysis: Pro-inflammatory cytokine Resistin inhibits glycolysis and cancer progression via down regulation of PDK1, 19/October/2014, 6.28 am

A recent study from the Institute for Cancer Research and CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Science, University […]